PRODUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-1 DURING HEMODIALYSIS WITH CELLULOSE MEMBRANES

被引:5
|
作者
FRITH, SE [1 ]
HOENICH, NA [1 ]
REDFERN, CPF [1 ]
GOODSHIP, THJ [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT MED, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND
来源
关键词
CHRONIC RENAL FAILURE; HEMODIALYSIS; HEMODIALYSIS MEMBRANE; BIOCOMPATIBILITY; INTERLEUKIN; 1; INTERLEUKIN 1 RECEPTOR ANTAGONIST;
D O I
10.1177/039139889401700906
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An in vivo cross-over study has investigated plasma and cellular levels of IL-1 (IL-1 alpha IL-1 beta and IL-1Ra) when using Cuprophan (C) and cellulose triacetate (CTA) membranes to assess the roles of complement activation and dialysate endotoxin content in the induction of cytokines during the dialysis procedure. The mean C5a level during Cuprophan dialysis was 29.9 +/- 0.63 ng/ml (Mean +/- SEM), while for the cellulose triacetate dialysis was 3.09 +/- 0.7 ng/ml. The endotoxin content of the dialysate was 0.31 +/- 0.34 EU/ ml and 0.68 +/- 1.39 EU/ml. These two factors failed to produce measurable changes in plasma or cellular IL-1 alpha and IL-1 beta levels during treatment. The plasma IL-1Ra levels predialysis were similar to those for normal controls (CTA 769 +/- 156 ng/ml, C739 +/- 93, normal controls 635 +/- 33) with a considerable day to day variation. A membrane independent fall in plasma IL-1Ra at 15 minutes was noted (CTA 420 +/- 92 ng/ml, C 503 +/- 139) with a return to pre-dialysis levels by the end of treament. Cellular IL-1Ra levels pre-dialysis were similar to the normal group - (CTA 1904 +/- 291 ng/ml, C 1564 +/- 292 and normal control 1971 +/- 368). However, on average, the values when using cellulose triacetate were 655 +/- 623 pg/ml higher than for Cuprophan (p=0.03). These findings indicate that the measurement of plasma cytokine levels is of limited use in the study of cytokine induction by the haemodialysis procedure and that IL-1Ra may be a better indicator of the host response fo cytokine stimuli during treatment. However, a considerable infer-patient and intra-treatment variation is present and further studies are required to elucidate the factors involved.
引用
收藏
页码:478 / 487
页数:10
相关论文
共 50 条
  • [1] INTERLEUKIN-1, INTERLEUKIN-1 RECEPTOR, AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
    ESPAT, NJ
    ROGY, MA
    COPELAND, EM
    MOLDAWER, LL
    PROCEEDINGS OF THE NUTRITION SOCIETY, 1994, 53 (02) : 393 - 400
  • [2] INTERLEUKIN-1 AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST
    DINARELLO, CA
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1991, 372 (04): : 239 - 239
  • [3] Interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    NUTRITION, 1995, 11 (05) : 492 - 494
  • [4] Graves' ophthalmopathy and gene polymorphisms in interleukin-1α, interleukin-1β, interleukin-1 receptor and interleukin-1 receptor antagonist
    Khalilzadeh, Omid
    Anvari, Mehdi
    Esteghamati, Alireza
    Mahmoudi, Mahdi
    Tahvildari, Maryam
    Rashidi, Armin
    Khosravi, Farideh
    Amirzargar, Aliakbar
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (06): : 614 - 619
  • [5] Induction of interleukin-1 and interleukin-1 receptor antagonist
    Dinarello, CA
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 981 - 993
  • [6] Balance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in the Development of Atherosclerosis - A Polymorphism in the Interleukin-1 Receptor Antagonist -
    Iida, Shinichiro
    Komiyama, Nobuyuki
    CIRCULATION JOURNAL, 2009, 73 (08) : 1401 - 1402
  • [7] INTERLEUKIN-1 RECEPTOR ANTAGONIST - AN INDEX OF DIALYSIS-INDUCED INTERLEUKIN-1 PRODUCTION
    PEREIRA, BJG
    KING, AJ
    FALAGAS, ME
    DINARELLO, CA
    NEPHRON, 1994, 67 (03): : 358 - 361
  • [8] INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST PRODUCTION DURING HEMODIALYSIS - WHICH CYTOKINE IS A SURROGATE MARKER FOR DIALYSIS-RELATED COMPLICATIONS
    DINARELLO, CA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 25 - 28
  • [9] Interleukin-1 receptor antagonist
    Bresnihan, B
    Cunnane, G
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 615 - +
  • [10] Interleukin-1 Receptor Antagonist
    Lennard, Andrew C.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2017, 37 (2-6) : 531 - 559